Desk›Healthcare› Fermenta Biotech Ltd
Fermenta Biotech Ltd
BSE 506414 · NSE FERMENTA · ISIN INE225B01021 · Group B · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹486.15
+4.13%
BSE close, 28 August 2026
₹1,430.79 cr
2.9 cr shares · Micro cap
₹459.16 cr
as published
22.7× · 4.54×
EPS ₹21.42 · BV ₹107.08
450.25 / 64.28
₹ cr, as filed
35
6 selected · 17%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -16.1% |
|---|---|
| Against 52-week low | +89.6% |
| Day change | +4.13% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹21.42 |
|---|---|
| Price / earnings | 22.70× |
| Price / book | 4.54× |
| Book value — derived, price ÷ P/B | ₹107.08 |
| Return on equity | 20.01% |
| Operating margin | 24.92% |
| Net margin | 13.40% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- 20.00%
- ROE as published
- 20.01%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 111.84 | 14.99 | 5.23 | 24.92% | 13.40% |
| Mar-26 · Q | 109.88 | 21.57 | 7.49 | 33.68% | 19.63% |
| FY25-26 | 450.25 | 64.28 | 22.13 | 27.02% | 14.28% |
Quarter on quarter
- Revenue, quarter on quarter
- +1.8%
- Net profit, quarter on quarter
- -30.5%
- Operating margin, quarter on quarter
- -876 bps
Disclosure profile 35 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Press Release | 2 |
| Board Outcome | 1 |
| Credit Rating | 1 |
| Investor Presentation | 1 |
| Results | 1 |
| Selected sub-total | 6 |
| Procedural | |
| Analyst / Investor Meet | 10 |
| General | 5 |
| AGM / EGM | 4 |
| Newspaper Publication | 4 |
| Annual Report | 1 |
| BRSR | 1 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| SAST | 1 |
| Trading Window | 1 |
| Procedural sub-total | 29 |
| Total | 35 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
35 filings · 6 selected · busiest 2026-08-11
Filing rhythm · the twelve most recent
2026-09-082026-10-09
SelectedProcedural
Filings
35 in the window · 17 earlier on record
-
9 October 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor(s) meeting(s) to be held on October 14, 2026.
Company Update / Analyst / Investor Meet View filing →
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
1 October 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor(s) meeting to be held on October 07, 2026.
Company Update / Analyst / Investor Meet View filing →
-
30 September 2026 ·
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Preeti Thakkar
Insider Trading / SAST / Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 View filing →
-
29 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor meeting to be held on October 5, 2026.
Company Update / Analyst / Investor Meet View filing →
-
29 September 2026 ·
Closure of Trading Window
Intimation of Closure of Trading Window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
24 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor(s) meeting.
Company Update / Analyst / Investor Meet View filing →
-
21 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor(s) meeting.
Company Update / Analyst / Investor Meet View filing →
-
17 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor(s) meet.
Company Update / Analyst / Investor Meet View filing →
-
16 September 2026 ·
Newspaper Publication
Copy of Newspaper Publication regarding notice to equity shareholders for transfer of shares to IEPF.
Company Update / Newspaper Publication View filing →
-
16 September 2026 ·
Dispatch Of Letters To Shareholders Regarding Transfer Of Equity Shares Of The Company To The Investor Education And Protection Fund ('IEPF') Account.
Dispatch of Letters to shareholders regarding transfer of Equity Shares of the Company to the Investor Education and Protection Fund ('IEPF') account.
Company Update / General View filing →
-
8 September 2026 ·
Press Release Regarding Exclusive Licence Agreement With Vellore Institute Of Technology ('VIT'), Vellore For Vitamin B12 Fortification Technology.
Press Release regarding exclusive Licence Agreement with Vellore Institute of Technology ('VIT'), Vellore for Vitamin B12 Fortification Technology.
Company Update / General View filing →
-
27 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor(s) meeting(s) to be held on September 3, 2026.
Company Update / Analyst / Investor Meet View filing →
-
26 August 2026 ·
Newspaper Publication
We hereby submit newspaper publication pertaining to Notice for Special window for transfer and dematerialization of physical securities.
Company Update / Newspaper Publication View filing →
-
17 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor meeting to be held on August 21, 2026.
Company Update / Analyst / Investor Meet View filing →
-
17 August 2026 ·
-
12 August 2026 ·
Newspaper Publication
Newspaper publication of Unaudited financial results for quarter ended June 30, 2026.
Company Update / Newspaper Publication View filing →
-
11 August 2026 ·
Declaration Of Voting Results Of The 74Th Annual General Meeting
Declaration of voting results of the 74th Annual General Meeting.
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizers report of 74th Annual General Meeting.
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Outcome of 74th Annual General Meeting.
AGM/EGM / AGM View filing →
-
11 August 2026 ·
Presentation For Shareholders At 74Th Annual General Meeting ('AGM')
Presentation for shareholders at 74th Annual General Meeting ('AGM')
Company Update / General View filing →
-
11 August 2026 ·
Investor Presentation
Earnings presentation - Q1/FY27
Company Update / Investor Presentation View filing →
-
11 August 2026 ·
Press Release / Media Release
Press release regarding unaudited financial results of Q1FY27.
Company Update / Press Release / Media Release View filing →
-
11 August 2026 ·
Unaudited Financial Results For Quarter Ended June 30, 2026.
Unaudited financial results for quarter ended June 30, 2026.
Result / Financial Results View filing →
-
11 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting And Unaudited Financial Results - June 30, 2026.
Outcome of Board meeting and unaudited financial results - June 30, 2026.
Board Meeting / Outcome of Board Meeting View filing →
-
10 August 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor(s) meeting(s).
Company Update / Analyst / Investor Meet View filing →
-
4 August 2026 ·
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026.
Fermenta Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve unaudited financial results ....
Board Meeting / Board Meeting View filing →
-
4 August 2026 ·
Press Release / Media Release
Press release - listing of shares on NSE
Company Update / Press Release / Media Release View filing →
-
31 July 2026 ·
Intimation Regarding Listing Of Equity Shares Of Fermenta Biotech Limited On National Stock Exchange Of India Limited.
Intimation regarding listing of equity shares of Fermenta Biotech Limited on National Stock Exchange of India Limited.
Company Update / General View filing →
-
24 July 2026 ·
Analyst / Investor Meet - Intimation
Intimation of investor meeting
Company Update / Analyst / Investor Meet View filing →
-
21 July 2026 ·
Newspaper Publication
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, we enclose herewith photocopy of the newspaper advertisement published pertaining ....
Company Update / Newspaper Publication View filing →
-
20 July 2026 ·
Business Responsibility and Sustainability Reporting (BRSR)
Business Responsibility and Sustainability Reporting for Financial Year 2025-26.
Others / Business Responsibility and Sustainability Reporting (BRSR) View filing →
-
20 July 2026 ·
Notice Of The 74Th Annual General Meeting Of Fermenta Biotech Limited To Be Held On August 11, 2026.
Notice of the 74th Annual General Meeting of Fermenta Biotech Limited to be held on August 11, 2026.
AGM/EGM / AGM View filing →
-
20 July 2026 ·
Reg. 34 (1) Annual Report.
Annual Report for Financial Year 2025-26.
Others / Reg. 34 (1) Annual Report View filing →
-
20 July 2026 ·
Cessation Of Subsidiary Viz. Fermenta Environment Solutions Private Limited Being A Wholly-Owned Subsidiary.
Cessation of subsidiary being a wholly-owned subsidiary pursuant to Share Subscription Agreement entered on July 20, 2026.
Company Update / General View filing →
RSS feed for Fermenta Biotech Ltd · the 50 most recent filings